evaluate novo nordisk on glp-1 agonists Bolsters Portfolio With OZEMPIC's New Approval GLP-1 Receptor Agonist Market Size,
Description
4,6 A key issue in the physiology of type 2 diabetes (T2DM) is the reduced incretin effect, which mainly results from decreased activity of the primary incretin hormones, GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic peptide)
First reported case of dulaglutide-induced acute pancreatitis with normal serum lipase level
doi: 10.1590/abd1806-4841.20164655 [DOI] [PMC free article] [PubMed] [Google Scholar] 186
GLP-1 receptors are expressed in the atrial myocardium and the sinoatrial node
